2020 Annual Meeting | Committee on Cannabis Law Program

MCLE Verification Form (85.8 KB)

Available after Purchase

E-book - Committee on Cannabis Law - 2020 Annual Meeting Program (17.82 MB)

Available after Purchase

1.1 - Article 29 and 29A – N.Y.S. Agriculture and Markets Law (0.70 MB)

Available after Purchase

1.1A - NYS Assembly Bill 6968 (0.65 MB)

Available after Purchase

1.2 - Industrial Hemp Agricultural Research Pilot Program – Program Guidance, Revised, August 2019 (0.30 MB)

Available after Purchase

1.3 - Changes to New York’s Industrial Hemp Agricultural Research Pilot Program FAQ, December 2019 (0.05 MB)

Available after Purchase

1.4 - Department-Conducted Research Partner Agreement - Industrial Hemp Growers (0.40 MB)

Available after Purchase

1.5 - USDA Interim Final Rule for the Establishment of a Domestic Hemp Production Program (Federal Register Excerpts) (2.16 MB)

Available after Purchase

1.6 - Department-Conducted Research Partner Agreement - Industrial Hemp Processor (CBD) (0.52 MB)

Available after Purchase

1.7 - Department of Agriculture and Markets, Frequently Asked Questions, July 2019 (0.04 MB)

Available after Purchase

1.8 - FDA Public Health Focus – FDA Regulation of Cannabis and Cannabis-Derived Products Including Cannabidiol (CBD) (0.92 MB)

Available after Purchase

1.9 - FDA Voices Perspectives, FDA is Committed to Sound, Science-based Policy on CBD (0.29 MB)

Available after Purchase

1.10 - What You Need to Know About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD (0.20 MB)

Available after Purchase

1.11 - ABA Passes Resolution Calling Upon Congress to Reform Federal Marijuana Policy (0.29 MB)

Available after Purchase

1.12 - As Consumer Litigation Mounts, CBD Companies Must Be Prepared (0.35 MB)

Available after Purchase

1.13 - Federal Marijuana Banking Bill Advances (a Little) (0.24 MB)

Available after Purchase

1.14 - Mikos - The Evolving Federal Response to State Marijuana Reforms (0.18 MB)

Available after Purchase

1.15 - Goldberg - More CBD Warning Letters from FDA- CBD Not GRAS (0.27 MB)

Available after Purchase

1.16 - NCIA-FDA - Public Comments (0.76 MB)

Available after Purchase

1.17 - NCIA - Adapting a Regulatory Framework for the Emerging Cannabis Industry (3.96 MB)

Available after Purchase

1.18 - Mikos - What are the Harms of CBD Use - Making Sense of the FDAs Recent Warning (0.35 MB)

Available after Purchase

2 - The Haze and Maze of Cannabis Law - How Will NY Courts Decide Cannabis-Related Business Discipline (0.49 MB)

Available after Purchase

3.1 - Representative Commercial Cannabis Cases (0.10 MB)

Available after Purchase

3.2 - The Unique Problems of Litigating in the Cannabis Industry (0.15 MB)

Available after Purchase

3.3 - U.S. Code 801 - Congressional findings and declarations - controlled (0.12 MB)

Available after Purchase

3.4 - Guidance Regarding Marijuana Enforcement - USDOJ (0.51 MB)

Available after Purchase

3.5 - Marijuana Enforcement - Office of the Attorney General (0.34 MB)

Available after Purchase

3.6 - NYSBA Ethics Opinion 1024 - Counseling Clients in Illegal Conduct - Medical Marijuana Law (0.96 MB)

Available after Purchase

3.7 - NYSBA Ethics Opinion 1177 - Counseling Clients in Illegal Conduct - Medical Marijuana Law (0.09 MB)

Available after Purchase

3.8 - Cannabis Engagement Letter - Recommended Additional Language (0.11 MB)

Available after Purchase

3.9 - The Ethical Issues Lawyers Face When They Wind Down a Practice - Plus an Update on Cannabis Law Ethics (0.19 MB)

Available after Purchase

3.10 - Litigation Financing Confidentiality and Marijuana Ethics for Lawyers (0.78 MB)

Available after Purchase

Faculty Biographies (0.71 MB)

Available after Purchase